Thank you very much, Amber, and a warm welcome to everyone joining us for this update call on our announcement today to acquire Bio-Techne. My name is Florian Schraeder. I'm the Head of Investor ...
Watertown-based Remix Therapeutics is heading for the public markets, lining up roughly $100 million in private financing as it inks an all-stock reverse merger with Passage Bio that will list the ...
Good morning, and welcome to the Passage Bio-Remix Therapeutics Merger Agreement Announcement Conference Call. I would like to remind you that this call is being recorded for replay. I will now turn ...
A new gene-editing company emerged from stealth on Tuesday with $230 million in committed financing, a reverse merger with a defunct oncology biotech, and a lead drug candidate licensed from a Chinese ...
An under-the-radar Bay Area biotech has brought in a $190 million series B with the goal of hatching a clutch of new companies to fly its drug candidates forward. Patient Square Capital led the ...
When writing a blockbuster movie script, screenplay writers are sure to include all the essential elements of a hit film. In the biotech world, the launch of Serapha Bio seems to follow this formula, ...
In a jam-packed third day of the UAW’s 39th Constitutional Convention, delegates nominated candidates for this year’s International Officer elections, voted to expand the definition of what ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results